Lauren White
CIK: 0001864430
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)1 (50.0%)
Compensation grants
Other (G, F, J, C, D, …)1 (50.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
SPTX
Seaport Therapeutics, Inc.
Officer
Discretionary Trading P&L
Holdings
About White Lauren
White Lauren (SEC CIK 0001864430) files insider reports with the SEC as Chief Financial Officer of Seaport Therapeutics, Inc. (SPTX).
Signal8 holds 1 ownership filing by White Lauren, a Form 4, filed on May 4, 2026. Those filings report 2 transactions, from Apr 30, 2026 to May 4, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on White Lauren's filings is in BOSTON, MA.
Recent filings by White Lauren
Other insiders filing for Seaport Therapeutics, Inc. (SPTX)
- HOMBACH ROBERT J., Director
- GAP Coinvestments CDA, L.P., Director
- General Atlantic (SP), L.P., Director
- PureTech Health plc, 10% Owner
- Zohar Daphne, Chief Executive Officer
- HEALY JAMES, Director